MAIA Biotechnology (MAIA) Non Operating Interest Expenses (2021 - 2024)

MAIA Biotechnology (MAIA) has reported Non Operating Interest Expenses for 4 consecutive years, with -$28.0 the latest figure, recorded in Q4 2024.

• On a quarterly basis, Non Operating Interest Expenses changed N/A year-over-year to -$28.0 in Q4 2024; TTM through Dec 2024 was $58.0, a 99.15% decrease from a year earlier, with the FY2024 full-year figure at $57.0, down 99.17% from the prior year.
• Non Operating Interest Expenses was -$28.0 for Q4 2024 at MAIA Biotechnology, down from $85.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $451306.0 in Q3 2021 and troughed at -$28.0 in Q4 2024.
• A 4-year average of $77865.9 and a median of $1715.5 in 2022 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses tumbled 99.97% in 2022 and jumped 8400.0% in 2024, its largest moves.
• Over 4 years, Non Operating Interest Expenses stood at $451306.0 in 2021, then tumbled by 98.86% to $5147.0 in 2022, then slumped by 99.98% to $1.0 in 2023, then plunged by 2900.0% to -$28.0 in 2024.
• The last three Non Operating Interest Expenses figures came in at -$28.0 (Q4 2024), $85.0 (Q3 2024), and $1.0 (Q3 2023), per Business Quant data.